Abstract:Tripartite motif (TRIM) 59 protein, a cancer-associated E3 ubiquitin ligase, plays important roles in various biological processes including innate immune response, autophagy, cell cycle, glycolysis and tumorigenicity. The mechanism of autophagy regulated by TRIM59 in non-small cell lung cancer (NSCLC) has been elucidated clearly. It has been demonstrated that TRIM59 was a novel molecule prognostic factor of NSCLC and frequently up-regulated in NSCLC patients, that was verified in The Cancer Genome Atlas (TCGA) datasets. Nevertheless, it still remains unclear of the correlation between TRIM59 expression and immune infiltrates as well as the predictive value of TRIM59 in lung adenocarcinoma (LUAD). In this study, analysis of TRIM59 expression in normal and tumor tissues indicated that TRIM59 was up-regulated in most tumor tissues based on RNA-seq datasets from TCGA and Genotype-Tissue Expression (GTEx) databases. The correlation analysis between TRIM59 expression and overall survival (OS), disease-specifical survival (DSS), disease-free interval (DFI) or progress free interval (PFI), suggested that high TRIM59 expression predicted adverse outcomes in LUAD (OS: P=0.00096; DSS: P=0.00056; DFI: P=0.0009; PFI: P=0.0012). The correlation analysis between TRIM59 and immune checkpoints revealed that TRIM59 was significantly correlated with most of immune checkpoints in TCGA database, and TRIM59 had significant correlation with TMB (P<0001), ESITIMATE score (P=0.04) or stromal score (P=0.005) in LUAD. Further investigation demonstrated that the significantly negative correlation between TRIM59 expression and tumor purity was only shown in LUAD (P=0.027). It was found that TRIM59 had significant correlation with gene markers on macrophage and neutrophil in Tumor Immune Estimation Resource (TIMER) database, indicating that TRIM59 expression in LUAD played an essential regulatory role in tumor immune progress including infiltration of macrophage and neutrophil. Functional enrichment analysis as well as correlation analysis between TRIM59 and clinical characteristics of LUAD patients was also performed in our report. Combined with previously reported prognostic role of TRIM59 in NSCLC, our results proved that TRIM59 is a prognosticator for LUAD and is correlated with immune infiltrates in LUAD. Funding Statement: This work was supported by the National Natural Science Foundation of China (81703072), The Natural Science Foundation of Zhejiang Province (LQ21H160027). Declaration of Interests: The authors have no conflict of interests.

TRIM37 Promotes Pancreatic Cancer Progression through Modulation of Cell Growth, Migration, Invasion, and Tumor Immune Microenvironment

TRIM37 promoted the growth and migration of the pancreatic cancer cells

TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT–GSK-3β–β-Catenin Signaling Pathway

TRIM21 is Decreased in Colitis-associated Cancer and Negatively Regulates Epithelial Carcinogenesis.

Knockdown of Tripartite Motif-Containing Protein 37 (trim37) Inhibits the Proliferation and Tumorigenesis in Colorectal Cancer Cells

E3 Ubiquitin Ligase TRIM29 Promotes Pancreatic Cancer Growth and Progression Via Stabilizing Yes-associated Protein 1.

Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway.

High TRIM59 Expression Predicts Adverse Outcomes and is Correlated with Immune Infiltrates in Lung Adenocarcinoma

TRIM47 Overexpression is a Poor Prognostic Factor and Contributes to Carcinogenesis in Non-Small Cell Lung Carcinoma

TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway

Ubiquitin Ligase TRIM15 Promotes the Progression of Pancreatic Cancer Via the Upregulation of the IGF2BP2-TLR4 Axis

TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination

Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer

Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling.

N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma

Up-regulation of Tripartite Motif-Containing 29 Promotes Cancer Cell Proliferation and Predicts Poor Survival in Colorectal Cancer

TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway

TRIM59 Overexpression Correlates with Poor Prognosis and Contributes to Breast Cancer Progression Through AKT Signaling Pathway.

TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression

TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond